Literature DB >> 24807605

Multiparametric MRI of rectal cancer in the assessment of response to therapy: a systematic review.

Andreas M Hötker1, Julio Garcia-Aguilar, Marc J Gollub.   

Abstract

BACKGROUND: Conventional MRI is limited in the assessment of nodal status and T status after neoadjuvant chemoradiotherapy. Multiparametric MRI strives to overcome these issues by directly measuring the local microcirculation and cellular environment, thus possibly allowing for a more reliable evaluation of response to therapy.
OBJECTIVE: We assessed the available literature for the value of multiparametric MRI sequences (diffusion-weighted and dynamic contrast-enhanced imaging) in determining the response to neoadjuvant chemoradiotherapy in patients with rectal cancer. DATA SOURCES: We conducted a systematic literature research in the PubMed database. STUDY SELECTION: English-language publications of the years 2000-2013 that applied multiparametric MRI in the neoadjuvant setting were included in this study. INTERVENTION: Patients received neoadjuvant chemoradiotherapy and MRI examinations for staging and assessment of response. MAIN OUTCOME MEASURES: Accuracy, specificity, and sensitivity of MRI in prediction/assessment of response to therapy were the included measures.
RESULTS: Forty-three studies were included in this review; 30 of them included diffusion-weighted imaging sequences, and 13 included dynamic contrast-enhanced MRI. Conventional MRI is limited in the accuracy of both T and N stages and response assessment. Diffusion-weighted imaging and dynamic contrast-enhanced MRIs showed additional value in both the prediction and detection of (complete) response to therapy compared with conventional sequences alone, as well as in correct N staging along with new experimental contrast agents. LIMITATIONS: The lack of standardization represents an important technical limitation. Most studies are conducted in an experimental setting; therefore, larger multicenter prospective studies are needed to verify the present findings.
CONCLUSIONS: Advanced, functional MRI techniques allow for the quantification of tumor biological processes, such as microcirculation, vascular permeability, and tissue cellularity. This new technology has begun to show potential advantages over standard morphologic imaging in the restaging of rectal cancer, allowing for more accurate prognostication of response and potentially introducing an era allowing earlier treatment alteration and more accurate noninvasive surveillance, which could improve patient outcomes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24807605     DOI: 10.1097/DCR.0000000000000127

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  32 in total

1.  Multiparametric MRI of rectal cancer-repeatability of quantitative data: a feasibility study.

Authors:  Bengi Gürses; Emre Altınmakas; Medine Böge; M Serhat Aygün; Onur Bayram; Emre Balık
Journal:  Diagn Interv Radiol       Date:  2020-03       Impact factor: 2.630

2.  Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer.

Authors:  Niels W Schurink; Simon R van Kranen; Maaike Berbee; Wouter van Elmpt; Frans C H Bakers; Sander Roberti; Joost J M van Griethuysen; Lisa A Min; Max J Lahaye; Monique Maas; Geerard L Beets; Regina G H Beets-Tan; Doenja M J Lambregts
Journal:  Eur Radiol       Date:  2021-02-10       Impact factor: 5.315

Review 3.  Update on advances and controversy in rectal cancer treatment.

Authors:  S Biondo; D Fraccalvieri; T Golda; R Frago; L Trenti; E Kreisler
Journal:  Tech Coloproctol       Date:  2016-01-12       Impact factor: 3.781

4.  Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging Sequences.

Authors:  Theodoros Soldatos; Shivani Ahlawat; Elizabeth Montgomery; Majid Chalian; Michael A Jacobs; Laura M Fayad
Journal:  Radiology       Date:  2015-09-21       Impact factor: 11.105

5.  Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.

Authors:  Sare Hosseini; NamPhong Nguyen; Mohammad Mohammadianpanah; Sepideh Mirzaei; Ali Mohammad Bananzadeh
Journal:  J Gastrointest Cancer       Date:  2019-12

6.  MRI can be used to assess advanced T-stage colon carcinoma as well as rectal carcinoma.

Authors:  Akitoshi Inoue; Shinichi Ohta; Norihisa Nitta; Masahiro Yoshimura; Tomoharu Shimizu; Masaji Tani; Ryoji Kushima; Kiyoshi Murata
Journal:  Jpn J Radiol       Date:  2016-10-18       Impact factor: 2.374

7.  Clinical Significance of the Endoscopic Finding in Predicting Complete Tumor Response to Preoperative Chemoradiation Therapy in Rectal Cancer.

Authors:  Sun Gyo Lim; Young Bae Kim; Seung Yeop Oh
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

8.  Assessment of colon and bladder crosstalk in an experimental colitis model using contrast-enhanced magnetic resonance imaging.

Authors:  R A Towner; N Smith; D Saunders; S B Van Gordon; K R Tyler; A B Wisniewski; B Greenwood-Van Meerveld; R E Hurst
Journal:  Neurogastroenterol Motil       Date:  2015-08-24       Impact factor: 3.598

9.  Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.

Authors:  Andreas M Hötker; Lisa Tarlinton; Yousef Mazaheri; Kaitlin M Woo; Mithat Gönen; Leonard B Saltz; Karyn A Goodman; Julio Garcia-Aguilar; Marc J Gollub
Journal:  Eur Radiol       Date:  2016-03-05       Impact factor: 5.315

10.  Primary squamous cell carcinoma of the rectum: An update and implications for treatment.

Authors:  Glen R Guerra; Cherng H Kong; Satish K Warrier; Andrew C Lynch; Alexander G Heriot; Samuel Y Ngan
Journal:  World J Gastrointest Surg       Date:  2016-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.